ACARIX Acarix AB (publ)

0.0152USD0.1540 SEK · STO-3.63%Mkt Cap: 18.80M USDP/E: —

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and adva…

Key Statistics

Company
Market Cap18.80M USD
Enterprise Value16.74M USD
Revenue (TTM)957.62K USD
Gross Profit614.00K USD
Net Income (TTM)-4.73M USD
Revenue/Share0.0008 USD
Last Price0.0152 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees8
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0009268717
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-4.69
EV/Revenue17.48
P/S19.64
P/B4.97
EPS (TTM)-0.0030 USD
EPS (Forward)0.00 USD
52W Range
0.01396% of range0.0339
52W High0.0339 USD
52W Low0.0139 USD
Profitability
Gross Margin84.74%
Oper. Margin-381.73%
EBITDA Margin0.00%
Profit Margin-653.32%
ROE-125.99%
ROA-99.51%
ROIC—
ROCE-125.78%
Growth
Revenue Growth21.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.67M USD
CapEx (TTM)74.51K USD
FCF Margin-270.76%
FCF Yield-13.79%
Net Debt-2.07M USD
Net Debt/EBITDA0.58
Net Debt/FCF—
Balance Sheet
Debt/Equity—
Current Ratio10.67
Quick Ratio8.90
Book Value/Sh0.0031 USD
Cash/Share0.0017 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)0.0394 USD
Upside (mean)+159.7%
Target Range0.0394 USD – 0.0394 USD
# Analysts1
Ownership
Shares Out.1.24B
Float1.10B
Insiders10.87%
Institutions7.48%
Technical
SMA 500.0189 (-19.8%)
SMA 2000.0242 (-37.5%)
Beta-0.29
S&P 52W Chg12.00%
Avg Vol (30d)1.51M
Avg Vol (10d)1.62M
Technical Indicators
RSI (14)30.2
MACD-0.0093
MACD Signal-0.0089
MACD Hist.-0.0004
BB Upper0.0190 USD
BB Middle0.0170 USD
BB Lower0.0150 USD
BB Width23.15%
ATR (14)0.0011 USD
Vol Ratio (20d)2.54x

About Acarix (STO: ACARIX)

›

Acarix (STO: ACARIX) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 8 employees.

The shares were at 0.1540 SEK on 19 November 2026, down 46.0% over 52 weeks. Its 52-week range is 0.1412 SEK to 0.3445 SEK: the price is 55.3% below the high and 9.1% above the low.

Its market capitalisation is 191.04M SEK.

Acarix reports return on equity of -126.0%, an operating margin of -381.7% and revenue up 21.5% year over year.

It holds more cash than debt, a net cash position of 21.00M SEK. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. One analyst covers the stock; their mean price target of 0.4000 SEK is 159.7% above the current price.